Markus Bickel
Experienced in Monkeypox

Markus Bickel

Frankfurt Am Main, HE, DE 
Experienced in Monkeypox
Frankfurt Am Main, HE, DE 
OverviewLocationsClinical Research

Overview

Markus Bickel practices in Frankfurt Am Main, Germany. Mr. Bickel is rated as an Experienced expert by MediFind in the treatment of Monkeypox. His top areas of expertise are HIV/AIDS, H1N1 Influenza, Hepatitis, and Hepatitis C.

His clinical research consists of co-authoring 63 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Monkeypox.

Gender
Male

Locations

Frankfurt Am Main, HE, Germany
Other Locations
Wuppertal, NW 42004, Germany
Nürnberger Str. 16, Deutschland, Berlin, BE 10789, Germany
Ebertplatz, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
A Phase III, Randomized, Multicenter, Open-Label Study in Adolescent and Adult Participants Comparing the Efficacy and Safety of Gepotidacin to Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
Enrollment Status: Completed
Publish Date: May 30, 2024
Intervention Type: Drug
Study Drugs: Gepotidacin, Ceftriaxone, Azithromycin
Study Phase: Phase 3
A Randomized, Double-Blind (Sponsor-unblinded), Placebo-Controlled, Adaptive Trial to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK3640254 in HIV-1 Infected Treatment-Naïve Adults
A Randomized, Double-Blind (Sponsor-unblinded), Placebo-Controlled, Adaptive Trial to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK3640254 in HIV-1 Infected Treatment-Naïve Adults
Enrollment Status: Completed
Publish Date: February 16, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

63 Total Publications

Delayed CD4 cell recovery in HIV-associated disseminated non-tuberculous mycobacterial disease: a case-control study.
Delayed CD4 cell recovery in HIV-associated disseminated non-tuberculous mycobacterial disease: a case-control study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bickel's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile